OxFORD Asset Management LLP boosted its stake in LivaNova PLC (NASDAQ:LIVN) by 209.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,136 shares of the company’s stock after acquiring an additional 15,668 shares during the period. OxFORD Asset Management LLP’s holdings in LivaNova were worth $1,607,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the business. Dimensional Fund Advisors LP raised its holdings in shares of LivaNova by 42.9% during the third quarter. Dimensional Fund Advisors LP now owns 1,317,901 shares of the company’s stock worth $92,331,000 after purchasing an additional 395,672 shares during the period. Schwab Charles Investment Management Inc. raised its holdings in shares of LivaNova by 3.9% during the third quarter. Schwab Charles Investment Management Inc. now owns 245,566 shares of the company’s stock worth $17,205,000 after purchasing an additional 9,139 shares during the period. Wells Fargo & Company MN raised its holdings in shares of LivaNova by 2.9% during the third quarter. Wells Fargo & Company MN now owns 395,126 shares of the company’s stock worth $27,683,000 after purchasing an additional 11,038 shares during the period. Schroder Investment Management Group acquired a new stake in shares of LivaNova during the third quarter worth $1,530,000. Finally, Legal & General Group Plc raised its holdings in shares of LivaNova by 8.9% during the third quarter. Legal & General Group Plc now owns 39,105 shares of the company’s stock worth $2,738,000 after purchasing an additional 3,207 shares during the period. 86.07% of the stock is currently owned by institutional investors.
A number of analysts have weighed in on the stock. Needham & Company LLC increased their target price on shares of LivaNova to $93.00 and gave the stock a “buy” rating in a report on Tuesday, November 21st. Canaccord Genuity reissued a “hold” rating and set a $76.00 target price on shares of LivaNova in a report on Tuesday, December 5th. Piper Jaffray Companies reissued a “buy” rating and set a $85.00 target price on shares of LivaNova in a report on Friday, November 3rd. BidaskClub cut shares of LivaNova from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 12th. Finally, Zacks Investment Research raised shares of LivaNova from a “hold” rating to a “buy” rating and set a $89.00 target price on the stock in a report on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. LivaNova has a consensus rating of “Buy” and an average target price of $79.71.
LivaNova PLC (NASDAQ:LIVN) opened at $80.33 on Friday. The company has a market cap of $3,870.00 and a PE ratio of 23.13. The company has a current ratio of 2.03, a quick ratio of 1.42 and a debt-to-equity ratio of 0.04. LivaNova PLC has a 12-month low of $44.58 and a 12-month high of $88.56.
LivaNova (NASDAQ:LIVN) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.76 by $0.17. The business had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. LivaNova had a net margin of 4.63% and a return on equity of 9.33%. The company’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.78 earnings per share. research analysts expect that LivaNova PLC will post 3.33 EPS for the current fiscal year.
In other news, Director Hugh M. Morrison sold 1,830 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $88.00, for a total transaction of $161,040.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $74.58, for a total transaction of $74,580.00. The disclosure for this sale can be found here. Insiders have sold 5,830 shares of company stock valued at $488,550 in the last 90 days. Insiders own 0.28% of the company’s stock.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.